摘要
目的探讨微创肺表面活性物质注入(less invasive surfactant administration,LISA)技术治疗新生儿呼吸窘迫综合征(neonatal respiratory distress syndrome,NRDS)的临床疗效、并发症及对血气分析的影响。方法选取2019年12月1日至2022年8月1日金华市中心医院收治的100例需行肺表面活性物质(pulmonary surfactant,PS)气管内注射给药的NRDS患儿,根据随机数字表法将患儿分为试验组(50例)和对照组(50例)。试验组患儿采用LISA技术进行PS治疗,对照组患儿采用气管插管-气管内滴入PS-拔管后经鼻持续气道正压通气技术进行PS治疗。比较两组患儿的临床治疗效果、血气指标、无创辅助通气时间、住院天数及并发症发生率。结果试验组患儿治疗总有效率高于对照组;PS治疗后1h试验组患儿的氧分压、血氧饱和度高于对照组,二氧化碳分压低于对照组;试验组患儿无创辅助通气时间短于对照组;支气管肺发育不良发生率低于对照组;差异均有统计学意义(P<0.05)。结论采用LISA技术进行PS治疗NRDS,可改善患儿的血气指标、缩短无创辅助通气时间、提高诊疗效果,降低支气管肺发育不良的风险,且不增加气管黏膜损伤、肺出血等并发症的发生率。
Objective To investigate the treatment of neonatal respiratory distress syndrome by less invasive surfactant administration(LISA)clinical efficacy,complications and influence on blood gas analysis.Methods A total of 100 cases of neonatal respiratory distress syndrome requiring pulmonary surfactant(PS)tracheal injection therapy and admitted to the Jinhua Central Hospital between December 1st 2019 and August 1st 2022 were randomly assigned into treatment group(50 cases)and control group(50 cases).The treatment group of children received PS treatment using LISA technology,while the control group of children received PS treatment using tracheal intubation tracheal instillation PS extubation followed by intubation-surfactant-extubation technology.The clinical treatment effect,blood gas analysis,non-invasive ventilation time,length of hospitalization,and incidence of complications were compared between the two groups.Results The total effective rate of treatment in the treatment group was higher than that in the control group;After 1 hour of PS treatment,the oxygen partial pressure and blood oxygen saturation of the treatment group were higher than those of the control group,while the carbon dioxide partial pressure was lower than that of the control group.The non-invasive assisted ventilation time of the treatment group was shorter than that of the control group.The incidence of bronchopulmonary dysplasia was lower than that of the control group.Their difference were statistically significant(P<0.05).Conclusion The use of LISA technology for PS treatment of NRDS can improve blood gas indicators,shorten non-invasive ventilation time,improve diagnostic and therapeutic effects,reduce the risk of bronchopulmonary dysplasia,and do not increase the incidence of complications such as tracheal mucosal injury and pulmonary hemorrhage in children.
作者
曹秀娟
应玲静
陈美仙
何剑邦
CAO Xiujuan;YING Lingjing;CHEN Meixian;HE Jianbang(Department of Neonatology,Jinhua Central Hospital,Jinhua 321000,Zhejiang,China)
出处
《中国现代医生》
2024年第12期49-52,共4页
China Modern Doctor
关键词
新生儿
呼吸窘迫综合征
LISA技术
血气分析
Neonatal
Respiratory distress syndrome
LISA technology
Blood gas analysis
